P533 Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practice
Calvo Moya, M I, Omella Usieto, I, El Hajra Martinez, I, Santos Perez, E, Gonzalez Lama, Y, Ruiz Antoran, B, Menchen Viso, B, Matallana Royo, V, Gonzalez Partida, I, De Lucas Tellez de Meneses, R, Bella del Castillo, P, Gonzalez Rodriguez, M, Vera Mendoza, M I
Published in Journal of Crohn's and colitis (27.05.2021)
Published in Journal of Crohn's and colitis (27.05.2021)
Get full text
Journal Article
P378 Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience
Calvo Moya, M I, Omella Usieto, I, Vera Mendoza, M I, Matallana Royo, V, Gonzalez Partida, I, Manso Manrique, M, Menchén Viso, B, De Lucas Téllez de Meneses, R, González Rodriguez, M, Bella del Castillo, P, González Lama, Y
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
P545 Deep remission assessed by endoscopy, magnetic resonance or intestinal ultrasound, in refractory Crohn’s disease patients in clinical remission with ustekinumab: a real-life single-centre experience
Calvo Moya, M I, Omella Usieto, I, González Lama, Y, Matallana Royo, V, González Partida, I, Menchen Viso, B, De Lucas Téllez de Meneses, R, González Rodriguez, M, Bella del Castillo, P, Vera Mendoza, M I
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article